BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15725015)

  • 21. Funnel metadynamics as accurate binding free-energy method.
    Limongelli V; Bonomi M; Parrinello M
    Proc Natl Acad Sci U S A; 2013 Apr; 110(16):6358-63. PubMed ID: 23553839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantum mechanical map for protein-ligand binding with application to beta-trypsin/benzamidine complex.
    Zhang DW; Xiang Y; Gao AM; Zhang JZ
    J Chem Phys; 2004 Jan; 120(3):1145-8. PubMed ID: 15268233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple Ligand Unbinding Pathways and Ligand-Induced Destabilization Revealed by WExplore.
    Dickson A; Lotz SD
    Biophys J; 2017 Feb; 112(4):620-629. PubMed ID: 28256222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular dynamics simulation of the docking of substrates to proteins.
    Di Nola A; Roccatano D; Berendsen HJ
    Proteins; 1994 Jul; 19(3):174-82. PubMed ID: 7937732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calculation of protein-ligand binding free energy by using a polarizable potential.
    Jiao D; Golubkov PA; Darden TA; Ren P
    Proc Natl Acad Sci U S A; 2008 Apr; 105(17):6290-5. PubMed ID: 18427113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure reveals basis for the inhibitor resistance of human brain trypsin.
    Katona G; Berglund GI; Hajdu J; Gráf L; Szilágyi L
    J Mol Biol; 2002 Feb; 315(5):1209-18. PubMed ID: 11827488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intriguing role of water in protein-ligand binding studied by neutron crystallography on trypsin complexes.
    Schiebel J; Gaspari R; Wulsdorf T; Ngo K; Sohn C; Schrader TE; Cavalli A; Ostermann A; Heine A; Klebe G
    Nat Commun; 2018 Sep; 9(1):3559. PubMed ID: 30177695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loop flexibility and solvent dynamics as determinants for the selective inhibition of cyclin-dependent kinase 4: comparative molecular dynamics simulation studies of CDK2 and CDK4.
    Park H; Yeom MS; Lee S
    Chembiochem; 2004 Dec; 5(12):1662-72. PubMed ID: 15505811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How Effectively Can Adaptive Sampling Methods Capture Spontaneous Ligand Binding?
    Betz RM; Dror RO
    J Chem Theory Comput; 2019 Mar; 15(3):2053-2063. PubMed ID: 30645108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ranking ligand binding affinities with avidin: a molecular dynamics-based interaction energy study.
    Wang J; Dixon R; Kollman PA
    Proteins; 1999 Jan; 34(1):69-81. PubMed ID: 10336384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SDOCKER: a method utilizing existing X-ray structures to improve docking accuracy.
    Wu G; Vieth M
    J Med Chem; 2004 Jun; 47(12):3142-8. PubMed ID: 15163194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Water access and ligand dissociation at the binding site of proteins.
    Yonetani Y
    J Chem Phys; 2018 Nov; 149(17):175102. PubMed ID: 30408972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular docking of balanol to dynamics snapshots of protein kinase A.
    Wong CF; Kua J; Zhang Y; Straatsma TP; McCammon JA
    Proteins; 2005 Dec; 61(4):850-8. PubMed ID: 16245317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of CDK2 active-site hydration: a method to design new inhibitors.
    Kríz Z; Otyepka M; Bártová I; Koca J
    Proteins; 2004 May; 55(2):258-74. PubMed ID: 15048820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An improved
    Calle LP; Espinosa JF
    Magn Reson Chem; 2017 Apr; 55(4):355-358. PubMed ID: 27661784
    [No Abstract]   [Full Text] [Related]  

  • 36. Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen.
    Ascenzi P; Coletta M; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
    J Mol Recognit; 1988 Jun; 1(3):130-7. PubMed ID: 3273224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.
    Renatus M; Bode W; Huber R; Stürzebecher J; Stubbs MT
    J Med Chem; 1998 Dec; 41(27):5445-56. PubMed ID: 9876114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A plausible identification of the secondary binding site in trypsin and trypsinogen.
    Andrade MH; Silva E; Mares-Guia M
    Braz J Med Biol Res; 1990; 23(12):1223-31. PubMed ID: 2136554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reranking docking poses using molecular simulations and approximate free energy methods.
    Lauro G; Ferruz N; Fulle S; Harvey MJ; Finn PW; De Fabritiis G
    J Chem Inf Model; 2014 Aug; 54(8):2185-9. PubMed ID: 25046765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of 3D-database molecular docking studies into homology models.
    Oshiro C; Bradley EK; Eksterowicz J; Evensen E; Lamb ML; Lanctot JK; Putta S; Stanton R; Grootenhuis PD
    J Med Chem; 2004 Jan; 47(3):764-7. PubMed ID: 14736258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.